“[W]e conclude that the FDA’s denial orders were sufficiently consistent with its predecisional guidance and thus did not run afoul of the change-in-position doctrine,” Justice Samuel Alito Jr. wrote for the unanimous court.

legal news

fbshare20 fblike20 pinterest20 stumble20  rss20  

“[W]e conclude that the FDA’s denial orders were sufficiently consistent with its predecisional guidance and thus did not run afoul of the change-in-position doctrine,” Justice Samuel Alito Jr. wrote for the unanimous court.

legal news

fbshare20 fblike20 pinterest20 stumble20  rss20